Literature DB >> 9990367

The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia).

C A Frost1, A C Green, G M Williams.   

Abstract

We report the association between skin pigmentation and individual sun exposure, and the occurrence of solar keratoses (SKs) in an unselected population, quantified for the first time. SKs were examined in a representative sample of 197 residents of the community of Nambour in Queensland, Australia. Estimates of sun exposure were combined with a measure of ultraviolet (UV) flux to estimate actual UV exposure, both occupational and recreational, during childhood and adult life. The number of episodes of painful sunburn was used as a measure of intermittent, intense UV exposure. Eight-three participants (43%) had at least one SK, while 35 (18%) had more than 10 SKs diagnosed. The age- and sex-adjusted odds ratios (ORs) for the development of SKs were higher in individuals with fair (OR = 14.1) or medium skin (OR = 6.5), compared with olive-skinned individuals. Individuals with poor ability to develop a suntan were similarly at increased risk compared with others. High levels of occupational UV exposure during adult life were confirmed as being strongly associated with prevalent SKs (OR = 2.4 for heavy/maximal adult exposure), with an even stronger association seen in those individuals with multiple SKs (OR = 4.3 for maximal adult exposure). Although no clear association was demonstrated between SK prevalence and accumulated childhood sun exposure, a history of even one episode of sunburn in childhood was strongly associated with SK prevalence (peak OR of 5.9 for one sunburn).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9990367     DOI: 10.1046/j.1365-2133.1998.02560.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

1.  Biologic markers of sun exposure and melanoma risk in women: pooled case-control analysis.

Authors:  Catherine M Olsen; Michael S Zens; Adele C Green; Therese A Stukel; C D'Arcy J Holman; Thomas Mack; J Mark Elwood; Elizabeth A Holly; Carlotta Sacerdote; Richard Gallagher; Anthony J Swerdlow; Bruce K Armstrong; Stefano Rosso; Connie Kirkpatrick; Roberto Zanetti; Julia Newton Bishop; Veronique Bataille; Yu-Mei Chang; Rona Mackie; Anne Østerlind; Marianne Berwick; Margaret R Karagas; David C Whiteman
Journal:  Int J Cancer       Date:  2010-11-16       Impact factor: 7.396

2.  Drug Intake and Actinic Keratosis: A Case-Control Study.

Authors:  Andrea Sechi; Ambra di Altobrando; Eugenio Cerciello; Elisa Maietti; Annalisa Patrizi; Francesco Savoia
Journal:  Dermatol Pract Concept       Date:  2021-04-12

3.  Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

Authors:  Craig A Elmets; Jaye L Viner; Alice P Pentland; Wendy Cantrell; Hui-Yi Lin; Howard Bailey; Sewon Kang; Kenneth G Linden; Michael Heffernan; Madeleine Duvic; Ellen Richmond; Boni E Elewski; Asad Umar; Walter Bell; Gary B Gordon
Journal:  J Natl Cancer Inst       Date:  2010-11-29       Impact factor: 13.506

4.  Cost-utility of first-line actinic keratosis treatments in Finland.

Authors:  Erkki J Soini; Taru Hallinen; Anna-Leena Sokka; Kari Saarinen
Journal:  Adv Ther       Date:  2015-05-26       Impact factor: 3.845

5.  Prevalence of lip and perioral Ephelides in beach workers.

Authors:  Eudes Euler de Souza Lucena; Ana Claudia de Queiroz Castro; Danielle Bezerra de Farias; Pérola Teixeira de Lima; Ericka Janine Dantas da Silveira; Kenio Costa de Lima
Journal:  An Bras Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.896

6.  Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.

Authors:  T Dirschka; P Radny; R Dominicus; H Mensing; H Brüning; L Jenne; L Karl; M Sebastian; C Oster-Schmidt; W Klövekorn; U Reinhold; M Tanner; D Gröne; M Deichmann; M Simon; F Hübinger; G Hofbauer; G Krähn-Senftleben; F Borrosch; K Reich; C Berking; P Wolf; P Lehmann; M Moers-Carpi; H Hönigsmann; K Wernicke-Panten; S Hahn; G Pabst; D Voss; M Foguet; B Schmitz; H Lübbert; R-M Szeimies
Journal:  Br J Dermatol       Date:  2013-04       Impact factor: 9.302

7.  Prevalence of sun exposure and its associated factors in southern Brazil: a population-based study.

Authors:  Rodrigo Pereira Duquia; Ana Maria Baptista Menezes; Hiram Larangeira de Almeida; Felipe Fossati Reichert; Iná da Silva dos Santos; Ricardo Lanzetta Haack; Bernardo Lessa Horta
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

8.  Cost for the treatment of actinic keratosis on the rise in Australia.

Authors:  Eshini Perera; Sean McGuigan; Rodney Sinclair
Journal:  F1000Res       Date:  2014-08-05

Review 9.  The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors.

Authors:  Elena Campione; Evelin Jasmine Paternò; Eleonora Candi; Mattia Falconi; Gaetana Costanza; Laura Diluvio; Alessandro Terrinoni; Luca Bianchi; Augusto Orlandi
Journal:  Drug Des Devel Ther       Date:  2015-10-29       Impact factor: 4.162

10.  A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes.

Authors:  David L A Wood; Nancy Lachner; Jean-Marie Tan; Stephanie Tang; Nicola Angel; Antonia Laino; Richard Linedale; Kim-Anh Lê Cao; Mark Morrison; Ian H Frazer; H Peter Soyer; Philip Hugenholtz
Journal:  mBio       Date:  2018-10-09       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.